Psoriasis and phenotype of patients with early inflammatory back pain

Annals of the Rheumatic Diseases

Volumn 72, Issue 4, 2013, Pages 566-571

  Richette, Pascal ^a,b   Tubach, Florence ^b,c,d   Breban, Maxime ^e,f   Viguier, Manuelle ^g   Bachelez, Hervé ^g   Bardin, Thomas ^a,b   Dougados, Maxime ^h  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d INSERM   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f INSTITUT COCHIN   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; LEUKOCYTE ANTIGEN; TRIACYLGLYCEROL;

ACHILLES TENDON; ADULT; ARTICLE; BACKACHE; BLOOD ANALYSIS; BONE EROSION; CONTROLLED STUDY; DACTYLITIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ECHOGRAPHY; ENTHESITIS; FAMILY HISTORY; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHYSICAL PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; X RAY ANALYSIS;

ACTIVITIES OF DAILY LIVING; ACUTE DISEASE; ADULT; BACK PAIN; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HLA-B27 ANTIGEN; HUMANS; LIPIDS; MALE; PHENOTYPE; PREVALENCE; PSORIASIS; QUALITY OF LIFE; RISK FACTORS; SPONDYLARTHRITIS; YOUNG ADULT;

EID: 84874443928     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201610     Document Type: Article

References (47)

1. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41. (Pubitemid 41815843)
2. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263-71. (Pubitemid 47069537)
3. Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol 2011;165:1037-43.
4. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med 2009;122:1150.e1-9.
5. Dougados M, Baeten D. Spondyloarthritis. Lancet 2011;377:2127-37.
6. Wilson FC, Icen M, Crowson CS, et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009;61:233-9.
7. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
8. Boyle DL, Kavanaugh A. The pathobiology of psoriatic synovium. Curr Opin Rheumatol 2008;20:404-7.
9. Brockbank JE, Stein M, Schentag CT, et al. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005;64:188-90. (Pubitemid 40193609)
10. Helliwell PS, Porter G, Taylor WJ. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 2007;66:113-17. (Pubitemid 46044869)
11. Porcher R, Said-Nahal R, D'Agostino MA, et al. Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families. Arthritis Rheum 2005;53:263-71. (Pubitemid 40530168)
12. Taylor WJ, Zmierczak HG, Helliwell PS. Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis. J Rheumatol 2005;32:974-7. (Pubitemid 40828064)
13. Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis 2005;64(Suppl. 2):ii55-7. (Pubitemid 40288523)
14. Chandran V, Barrett J, Schentag CT, et al. Axial psoriatic arthritis: update on a longterm prospective study. J Rheumatol 2009;36:2744-50.
15. Gladman DD. Axial disease in psoriatic arthritis. Curr Rheumatol Rep 2007;9:455-60. (Pubitemid 350305202)
16. Sieper J, Rudwaleit M, Khan MA, et al. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol 2006;20:401-17. (Pubitemid 43843063)
17. Harrison BJ, Silman AJ, Barrett EM, et al. Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol 1997;24:1744-9.
18. Morgan C, Lunt M, Bunn D, et al. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis. Rheumatology (Oxford) 2007;46:1819-23. (Pubitemid 350168298)
19. Stafford L, Kane D, Murphy E, et al. Psoriasis predicts a poor short-term outcome in patients with spondylarthropathy. Arthritis Rheum 2001;45:485-93. (Pubitemid 33140583)
20. Chung HY, Machado P, Van der Heijde D, et al. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis. Published Online First: 11 October 2011. doi: 10.1136/annrheumdis-2011-200180.
21. Chung HY, Machado P, Van der Heijde D, et al. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann Rheum Dis 2011;70:1930-6.
22. Dougados M, D'Agostino MA, Benessiano J, et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011;78:598-603.
23. Calin A, Porta J, Fries J F, et al. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-14. (Pubitemid 8104225)
24. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006;54:569-78. (Pubitemid 43228633)
25. http://www.lacohortedesir.fr/.
26. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C, et al. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 2003;48:523-33. (Pubitemid 36278022)
27. Heuft-Dorenbosch L, Landewé R, Weijers R, et al. Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 2007;66:92-8. (Pubitemid 46044866)
28. Rudwaleit M, Haibel H, Baraliakos X, et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-27.
29. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
30. Mease PJ. Psoriatic arthritis: update on pathophysiology, assessment and management. Ann Rheum Dis 2011;70(Suppl. 1):i77-84.
31. Fitzgerald O, Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther 2009;11:214.
32. Hébert HL, Ali FR, Bowes J, et al. Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy. Br J Dermatol 2012;166:474-82.
33. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-41. (Pubitemid 44547793)
34. Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011;124:775.e1-6.
35. Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, et al. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92. (Pubitemid 39643120)
36. Szabo SM, Levy AR, Rao SR, et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 2011;63:3294-304.
37. Husted JA, Thavaneswaran A, Chandran V, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res (Hoboken) 2011;63:1729-35.
38. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011;8:e1001098.
39. Pérez Alamino R, Maldonado Cocco JA, Citera G, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 2011;38:1656-60.
40. Fernández-Sueiro JL, Willisch A, Pértega-Díaz S, et al. Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum 2009;61:386-92.
41. Edmunds L, Elswood J, Kennedy LG, et al. Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis. J Rheumatol 1991;18:696-8.
42. McGonagle D, Lories RJ, Tan AL, et al. The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007;56:2482-91. (Pubitemid 47237267)
43. McGonagle D, Ash Z, Dickie L, et al. The early phase of psoriatic arthritis. Ann Rheum Dis 2011;70(Suppl. 1):i71-6.
44. Gisondi P, Tinazzi I, El-Dalati G, et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 2008;67:26-30.
45. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 1998;57:135-40.
46. Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005;64(Suppl. 2):ii3-8. (Pubitemid 40288511)
47. Gorter S, Van der Heijde DM, Van der Linden S, et al. Psoriatic arthritis: performance of rheumatologists in daily practice. Ann Rheum Dis 2002;61:219-24. (Pubitemid 34177751)